LIVN EBITDA | LivaNova PLC

LivaNova PLC (LIVN) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income $49.48M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income $41.47M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income $54.01M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income $54.18M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2014-04-25 to 2016-12-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	$49.48M	(m)	$390.59M	(m)	$31.55M*	$66.59M*	$116.92M	$53.66M	$158.13M	-$90.20M
2026-03-31	Reported	(m)	$41.47M	(m)	$362.26M	(m)	$14.29M	$15.22M	$118.51M	$58.70M	$143.57M	$4.34M
2025-09-30	Reported	(m)	$54.01M	(m)	$357.75M	(m)	$22.88M*	$85.06M*	$112.90M	$48.58M	$138.52M	$7.11M
2025-06-30	Reported	(m)	$54.18M	(m)	$352.52M	(m)	$15.15M*	$62.92M*	$113.54M	$47.19M	$137.78M	$6.15M
2025-03-31	Reported	(m)	$48.62M	(m)	$316.86M	(m)	$10.79M	$23.97M	$100.60M	$37.88M	$129.15M	$11.66M
2024-09-30	Reported	(m)	$35.62M	(m)	$318.12M	(m)	$18.15M*	$50.99M*	$97.09M	$48.80M	$127.43M	$11.53M
2024-06-30	Reported	(m)	$40.17M	(m)	$318.57M	(m)	$12.16M*	$43.36M*	$103.70M	$44.74M	$125.13M	$5.23M
2024-03-31	Reported	(m)	$16.25M	(m)	$294.91M	(m)	$6.40M	$9.98M	$91.70M	$45.66M	$125.68M	$7.72M
2023-09-30	Reported	(m)	$4.46M	(m)	$286.11M	(m)	$8.72M*	$18.14M*	$84.31M	$46.54M	$134.79M	$5.31M
2023-06-30	Reported	(m)	$17.38M	(m)	$293.88M	(m)	$5.66M*	-$17.94M*	$88.69M	$51.12M	$125.87M	$4.10M
2023-03-31	Reported	(m)	-$2.34M	(m)	$263.42M	(m)	$7.68M	$20.76M	$89.33M	$49.99M	$124.13M	$2.37M
2022-09-30	Reported	(m)	-$131.97M	(m)	$252.60M	(m)	$6.04M*	$35.64M*	$81.69M	$35.73M	$114.63M	$1.29M
2022-06-30	Reported	(m)	$31.76M	(m)	$254.15M	(m)	$6.13M*	-$10.24M*	$69.80M	$34.23M	$116.48M	$2.52M
2022-03-31	Reported	(m)	$9.51M	(m)	$240.18M	(m)	$5.21M	$25.82M	$71.73M	$40.92M	$118.53M	$2.54M
2021-12-31	Reported	(m)	$24.75M	(m)	$270.06M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	(m)	$16.42M	(m)	$253.22M	(m)	$3.27M*	$23.95M*	$84.55M	$42.13M	$109.04M	$1.86M
2021-06-30	Reported	(m)	-$36.26M	(m)	$264.48M	(m)	$6.40M*	$25.63M*	$92.20M	$52.56M	$122.75M	$3.91M
2021-03-31	Reported	(m)	-$5.70M	(m)	$247.60M	(m)	$8.22M	$19.48M	$84.19M	$44.63M	$115.68M	$2.64M
2020-12-31	Reported	(m)	-$249.02M	(m)	$269.56M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	(m)	-$7.55M	(m)	$240.08M	(m)	$10.49M*	$8.66M*	$92.45M	$47.37M	$104.04M	-$3.99M
2020-06-30	Reported	(m)	-$16.74M	(m)	$182.21M	(m)	$9.36M*	-$19.02M*	$65.73M	$25.15M	$102.74M	$66.28M
2020-03-31	Reported	(m)	-$581.00K	(m)	$242.40M	(m)	$8.60M	-$106.05M	$68.92M	$35.90M	$120.18M	-$44.71M
2019-12-31	Reported	(m)	-$143.98M	(m)	$287.59M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	(m)	$25.76M	(m)	$268.61M	(m)	$6.00M*	-$76.59M*	$86.13M	$45.90M	$123.02M	-$10.65M
2019-06-30	Reported	(m)	-$29.88M	(m)	$277.17M	(m)	$5.05M*	-$19.39M*	$74.94M	$34.54M	$127.21M	-$6.16M
2019-03-31	Reported	(m)	-$20.78M	(m)	$250.80M	(m)	$5.74M	$1.97M	$84.25M	$43.58M	$125.70M	-$6.61M
2018-12-31	Reported	(m)	-$276.45M	(m)	$296.98M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	(m)	-$5.76M	(m)	$272.08M	(m)	$11.83M*	$51.06M*	$94.30M	$42.42M	$115.14M	-$2.66M
2018-06-30	Reported	(m)	$21.61M	(m)	$287.50M	(m)	$6.64M*	$28.14M*	$91.99M	$34.22M	$123.44M	-$1.03M
2018-03-31	Reported	(m)	$12.53M	(m)	$250.40M	(m)	$5.85M	$20.39M	$84.60M	$31.75M	$104.16M	$3.89M
2017-12-31	Reported	(m)	$18.94M	(m)	$278.36M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	(m)	$30.02M	(m)	$251.25M	(m)	$9.08M*	$42.10M*	$87.75M	$22.90M	$97.20M	$1.91M
2017-06-30	Reported	(m)	$27.77M	(m)	$255.84M	(m)	$7.36M*	-$1.65M*	$84.02M	$33.83M	$94.26M	$3.26M
2017-03-31	Reported	(m)	$19.75M	(m)	$226.82M	(m)	$7.57M	$33.21M	$79.97M	$20.39M	$87.34M	$5.66M
2016-12-31	Reported	$45.83M	(m)	(m)	(m)	74.43%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	$45.47M	(m)	(m)	(m)	15.40%	$12.27M*	$36.76M*	$106.45M	$32.17M	$109.23M	$9.73M
2016-06-30	Reported	$40.05M	(m)	(m)	(m)	12.47%	$8.52M*	$2.98M*	$130.65M	$30.21M	$120.64M	$8.42M
2016-03-31	Reported	-$12.54M	(m)	(m)	(m)	-4.37%	$8.14M	$9.60M	$123.57M	$31.69M	$115.87M	-$1.26M
2015-10-18	Reported	-$22.77M	(m)	(m)	(m)	-33.72%	$1.39M*	$30.72M*	$9.54M	$14.74M	$41.19M	-$1.46M
2015-09-30	Reported	(m)	$0.00	(m)	(m)	(m)	(m)	(m)	(m)	$0.00	$0.00	$0.00
2015-07-24	Reported	$22.76M	(m)	(m)	(m)	28.09%	$1.68M*	$18.74M*	$9.43M	$9.80M	$33.71M	$6.80M
2015-04-24	Reported	$37.01M	(m)	(m)	(m)	33.67%	$1.20M	$16.17M	$7.59M	$10.69M	$29.69M	$6.35M
2014-10-24	Reported	(m)	$26.26M	(m)	(m)	(m)	(m)	(m)	$6.77M	$10.82M	$29.57M	$9.02M

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	$199.39M	(m)	$1.39B	(m)	$81.05M	$254.34M	$448.18M	$185.76M	$548.81M	$21.64M
2024-12-31	Reported	(m)	$129.05M	(m)	$1.25B	(m)	$47.11M	$183.04M	$399.95M	$182.51M	$508.88M	$25.06M
2023-12-31	Reported	(m)	-$68.50M	(m)	$1.15B	(m)	$34.98M	$74.91M	$397.73M	$193.82M	$502.70M	-$98.88M
2022-12-31	Reported	(m)	-$76.75M	(m)	$1.02B	(m)	$26.52M	$69.92M	$314.58M	$155.81M	$469.24M	$11.05M
2022-09-30	Rolling	(m)	-$65.96M*	(m)	$1.02B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-06-30	Rolling	(m)	$82.44M*	(m)	$1.02B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-03-31	Rolling	(m)	$14.42M*	(m)	$1.03B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-12-31	Reported	(m)	-$784.00K	(m)	$1.04B	(m)	$25.48M	$102.54M	$329.37M	$183.41M	$471.90M	$11.20M
2021-12-31	Rolling	(m)	-$784.00K*	(m)	$1.04B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Rolling	(m)	-$274.56M*	(m)	$1.03B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-06-30	Rolling	(m)	-$298.54M*	(m)	$1.02B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-03-31	Rolling	(m)	-$279.02M*	(m)	$939.45M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-12-31	Reported	(m)	-$273.90M	(m)	$934.24M	(m)	$35.02M	-$79.42M	$339.48M	$152.90M	$446.56M	-$960.00K
2020-12-31	Rolling	(m)	-$273.90M*	(m)	$934.24M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Rolling	(m)	-$168.85M*	(m)	$952.28M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-06-30	Rolling	(m)	-$135.54M*	(m)	$980.80M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-03-31	Rolling	(m)	-$148.67M*	(m)	$1.08B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-12-31	Reported	(m)	-$171.55M	(m)	$1.08B	(m)	$24.69M	-$91.14M	$360.37M	$146.85M	$528.47M	-$30.37M
2019-12-31	Rolling	(m)	-$168.87M*	(m)	$1.08B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Rolling	(m)	-$301.35M*	(m)	$1.09B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-06-30	Rolling	(m)	-$332.86M*	(m)	$1.10B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-03-31	Rolling	(m)	-$281.38M*	(m)	$1.11B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-12-31	Reported	(m)	-$248.07M	(m)	$1.11B	(m)	$37.19M	$120.49M	$361.32M	$145.95M	$464.97M	-$69.63M
2018-12-31	Rolling	(m)	-$248.07M*	(m)	$1.11B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Rolling	(m)	$47.32M*	(m)	$1.09B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	Rolling	(m)	$83.10M*	(m)	$1.07B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	Rolling	(m)	$89.27M*	(m)	$1.04B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-12-31	Reported	(m)	$96.49M	(m)	$1.01B	(m)	$32.93M	$91.34M	$353.19M	$109.52M	$380.10M	$49.95M
2017-12-31	Rolling	(m)	$96.49M*	(m)	$1.01B*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Rolling	(m)	$62.67M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-06-30	Rolling	(m)	$63.02M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-03-31	Rolling	(m)	$60.26M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	Reported	$118.81M	(m)	(m)	(m)	12.31%	$38.36M	$90.15M	$367.85M	$82.08M	$355.16M	$5.11M
2016-12-31	Rolling	(m)	$31.44M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-04-24	Reported	$95.46M	(m)	(m)	(m)	32.74%	$6.69M	$79.68M	$27.31M	$42.24M	$123.62M	$31.45M
2014-04-25	Reported	$85.64M	(m)	(m)	(m)	30.37%	$15.22M	$54.20M	$27.36M	$45.22M	$120.64M	$24.99M
2013-04-26	Reported	$82.98M*	$78.35M	$4.64M	(m)	(m)	$9.71M	$79.05M	$21.91M	$41.55M	$112.52M	$28.92M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Integer Holdings Corp (ITGR)	United States	$4.289B	25.17
TransMedics Group, Inc. (TMDX)	United States	$2.911B	15.17
Axogen, Inc. (AXGN)	United States	$2.329B	-73.83
BIOLIFE SOLUTIONS INC (BLFS)	United States	$1.887B	23.80
CONMED Corp (CNMD)	United States	$1.353B	26.72
Ceribell, Inc. (CBLL)	United States	$0.916B	-11.27
CapsoVision, Inc (CV)	United States	$0.310B	-12.68
Electromed, Inc. (ELMD)	United States	$0.233B	31.13
EDAP TMS SA (FOCL)		$0.171B
Stereotaxis, Inc. (STXS)	United States	$0.130B	-7.53